GRAL vs ICLR Valuation Comparison 2026 — Intrinsic Value Analysis

Quick Summary — GRAL scores higher on quality with 7.0/10 vs ICLR's 2.4/10. GRAL trades at $59.90 while ICLR trades at $137.54. Both analyzed daily using SEC EDGAR data across 13 institutional models.

GRAL

Diagnostics & Research

GRAIL, Inc.

Quality

7.0

out of 10

Value Trap

6

SAFE

Price

$59.90

Last close

Models

12/13

Active

VS

ICLR

Diagnostics & Research

ICON plc

Quality

2.4

out of 10

Value Trap

6

SAFE

Price

$137.54

Last close

Models

13/13

Active

GRAL

2 models active

Limited to 2/13 visible models

ICLR

Earnings Power Value sees +23.9% upside

Quality 2.4/10 — below average

GRAL vs ICLR — Fair Value Comparison

GRAL

ICLR

Market Price Model 1 Model 2

Model-by-Model Comparison

Model	Type	GRAL Fair Value	GRAL Upside	ICLR Fair Value	ICLR Upside
Bayesian DCF	Intrinsic	$17.83	-70.2%	$53.66	-61.0%
Earnings Power Value	Intrinsic	$34.28	-37.0%	$153.82	+23.9%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

GRAL vs ICLR — Which Stock Is More Undervalued in 2026?

GRAL scores higher with a 7.0/10 quality rating vs ICLR's 2.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

How Do GRAL and ICLR Valuations Compare?

At $59.90, GRAL trades +70.2% above its Bayesian DCF fair value of $17.83, while ICLR at $137.54 trades +61.0% above its estimate of $53.66. GRAL shows a wider gap between price and intrinsic value.

Quality of Company: GRAL vs ICLR

GRAL earns a Quality of Company score of 7.0/10 compared to ICLR's 2.4/10. This is a significant quality gap — the higher-scoring company demonstrates materially stronger fundamentals across profitability, growth consistency, and balance sheet health. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.

Value Trap Risk: GRAL vs ICLR

GRAL carries a SAFE value trap risk (6/100) while ICLR shows SAFE risk (6/100). Both companies show manageable value trap risk, suggesting their current valuations are not artificially depressed by fundamental deterioration.

Both in Diagnostics & Research

Both GRAL and ICLR operate in Diagnostics & Research, which has 48 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).

2 of 13 MODELS UNLOCKED

You’re comparing 2 models. 11 more have an opinion.

11 hidden models compare GRAL vs ICLR differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.

11 additional fair values per stock Full confidence breakdown Live terminal — 5,000+ stocks

Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day

See All 13 Models — $0.90/day

We don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.

GRAL

View Full GRAIL, Inc. Analysis →

ICLR

View Full ICON plc Analysis →

See all Diagnostics & Research stocks →